Cannell & Co’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-63,499	Closed	-$347K	–	255
2019 Q1	$347K	Hold	63,499	–	–	0.01%	205
2018 Q4	$193K	Sell	63,499 -32,292	-34%	-$112K	0.01%	232
2018 Q3	$402K	Hold	95,791	–	–	0.01%	212
2018 Q2	$370K	Hold	95,791	–	–	0.01%	214
2018 Q1	$607K	Sell	95,791 -128	-0.1%	-$1.06K	0.02%	192
2017 Q4	$774K	Sell	95,919 -14,105	-13%	-$132K	0.03%	186
2017 Q3	$1.26M	Sell	110,024 -26,838	-20%	-$282K	0.04%	160
2017 Q2	$1.33M	Sell	136,862 -17,244	-11%	-$352K	0.05%	154
2017 Q1	$3.73M	Sell	154,106 -45,820	-23%	-$1.15M	0.13%	120
2016 Q4	$6.42M	Sell	199,926 -4,918	-2%	-$210K	0.23%	95
2016 Q3	$10.2M	Sell	204,844 -382	-0.2%	-$15.9K	0.37%	73
2016 Q2	$8.7M	Buy	205,226 +55,632	+37%	+$3.03M	0.32%	78
2016 Q1	$9.85M	Buy	149,594 +15,989	+12%	+$835K	0.35%	70
2015 Q4	$7.75M	Hold	133,605	–	–	0.25%	83
2015 Q3	$8.95M	Hold	133,605	–	–	0.29%	82
2015 Q2	$13M	Buy	133,605 +90,810	+212%	+$8.64M	0.37%	72
2015 Q1	$4M	Buy	42,795 +1,271	+3%	+$108K	0.12%	120
2014 Q4	$3.69M	Buy	41,524 +33,212	+400%	+$2.42M	0.11%	117
2014 Q3	$574K	Buy	8,312 +1,271	+18%	+$67.9K	0.02%	200
2014 Q2	$404K	Buy	7,041 +3,558	+102%	+$181K	0.01%	212
2014 Q1	$138K	Hold	3,483	–	–	﹤0.01%	267
2013 Q4	$146K	Buy	+3,483	New	+$101K	0.01%	118

Other funds holding MACK